Report Detail
Global mRNA Vaccine Market Insights, Forecast to 2025
- RnM2753637 |
- 07 July, 2020 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
mRNA Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the mRNA Vaccine market is segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segment by Application, the mRNA Vaccine market is segmented into
Infectious Disease
Cancer
Other
Regional and Country-level Analysis
The mRNA Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the mRNA Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and mRNA Vaccine Market Share Analysis
mRNA Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in mRNA Vaccine business, the date to enter into the mRNA Vaccine market, mRNA Vaccine product introduction, recent developments, etc.
The major vendors covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 Study Coverage
- 1.1 mRNA Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key mRNA Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global mRNA Vaccine Market Size Growth Rate by Type
- 1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
- 1.4.3 Individualized Cancer Treatment MRNA Vaccine
- 1.4.4 Infectious Disease Treatment MRNA Vaccine
- 1.4.5 Infection Prevention MRNA Vaccine
- 1.5 Market by Application
- 1.5.1 Global mRNA Vaccine Market Size Growth Rate by Application
- 1.5.2 Infectious Disease
- 1.5.3 Cancer
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global mRNA Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global mRNA Vaccine Revenue 2015-2026
- 2.1.2 Global mRNA Vaccine Sales 2015-2026
- 2.2 Global mRNA Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global mRNA Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global mRNA Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global mRNA Vaccine Competitor Landscape by Players
- 3.1 mRNA Vaccine Sales by Manufacturers
- 3.1.1 mRNA Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 mRNA Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 mRNA Vaccine Revenue by Manufacturers
- 3.2.1 mRNA Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by mRNA Vaccine Revenue in 2019
- 3.2.5 Global mRNA Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 mRNA Vaccine Price by Manufacturers
- 3.4 mRNA Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 mRNA Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers mRNA Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into mRNA Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global mRNA Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global mRNA Vaccine Sales by Type (2015-2020)
- 4.1.2 Global mRNA Vaccine Revenue by Type (2015-2020)
- 4.1.3 mRNA Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global mRNA Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global mRNA Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global mRNA Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 mRNA Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global mRNA Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global mRNA Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global mRNA Vaccine Sales by Application (2015-2020)
- 5.1.2 Global mRNA Vaccine Revenue by Application (2015-2020)
- 5.1.3 mRNA Vaccine Price by Application (2015-2020)
- 5.2 mRNA Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global mRNA Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global mRNA Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global mRNA Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America mRNA Vaccine by Country
- 6.1.1 North America mRNA Vaccine Sales by Country
- 6.1.2 North America mRNA Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America mRNA Vaccine Market Facts & Figures by Type
- 6.3 North America mRNA Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe mRNA Vaccine by Country
- 7.1.1 Europe mRNA Vaccine Sales by Country
- 7.1.2 Europe mRNA Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe mRNA Vaccine Market Facts & Figures by Type
- 7.3 Europe mRNA Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific mRNA Vaccine by Region
- 8.1.1 Asia Pacific mRNA Vaccine Sales by Region
- 8.1.2 Asia Pacific mRNA Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific mRNA Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific mRNA Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America mRNA Vaccine by Country
- 9.1.1 Latin America mRNA Vaccine Sales by Country
- 9.1.2 Latin America mRNA Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America mRNA Vaccine Market Facts & Figures by Type
- 9.3 Central & South America mRNA Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa mRNA Vaccine by Country
- 10.1.1 Middle East and Africa mRNA Vaccine Sales by Country
- 10.1.2 Middle East and Africa mRNA Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa mRNA Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa mRNA Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Moderna Therapeutics
- 11.1.1 Moderna Therapeutics Corporation Information
- 11.1.2 Moderna Therapeutics Description and Business Overview
- 11.1.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
- 11.1.5 Moderna Therapeutics Related Developments
- 11.2 CureVac
- 11.2.1 CureVac Corporation Information
- 11.2.2 CureVac Description and Business Overview
- 11.2.3 CureVac Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 CureVac mRNA Vaccine Products Offered
- 11.2.5 CureVac Related Developments
- 11.3 Translate Bio
- 11.3.1 Translate Bio Corporation Information
- 11.3.2 Translate Bio Description and Business Overview
- 11.3.3 Translate Bio Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Translate Bio mRNA Vaccine Products Offered
- 11.3.5 Translate Bio Related Developments
- 11.4 BioNTech
- 11.4.1 BioNTech Corporation Information
- 11.4.2 BioNTech Description and Business Overview
- 11.4.3 BioNTech Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 BioNTech mRNA Vaccine Products Offered
- 11.4.5 BioNTech Related Developments
- 11.5 Sangamo Therapeutics
- 11.5.1 Sangamo Therapeutics Corporation Information
- 11.5.2 Sangamo Therapeutics Description and Business Overview
- 11.5.3 Sangamo Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sangamo Therapeutics mRNA Vaccine Products Offered
- 11.5.5 Sangamo Therapeutics Related Developments
- 11.6 Argos Therapeutics
- 11.6.1 Argos Therapeutics Corporation Information
- 11.6.2 Argos Therapeutics Description and Business Overview
- 11.6.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Argos Therapeutics mRNA Vaccine Products Offered
- 11.6.5 Argos Therapeutics Related Developments
- 11.7 In-Cell-Art
- 11.7.1 In-Cell-Art Corporation Information
- 11.7.2 In-Cell-Art Description and Business Overview
- 11.7.3 In-Cell-Art Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 In-Cell-Art mRNA Vaccine Products Offered
- 11.7.5 In-Cell-Art Related Developments
- 11.8 eTheRNA
- 11.8.1 eTheRNA Corporation Information
- 11.8.2 eTheRNA Description and Business Overview
- 11.8.3 eTheRNA Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 eTheRNA mRNA Vaccine Products Offered
- 11.8.5 eTheRNA Related Developments
- 11.9 Ethris
- 11.9.1 Ethris Corporation Information
- 11.9.2 Ethris Description and Business Overview
- 11.9.3 Ethris Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Ethris mRNA Vaccine Products Offered
- 11.9.5 Ethris Related Developments
- 11.10 Tiba Biotechnology
- 11.10.1 Tiba Biotechnology Corporation Information
- 11.10.2 Tiba Biotechnology Description and Business Overview
- 11.10.3 Tiba Biotechnology Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Tiba Biotechnology mRNA Vaccine Products Offered
- 11.10.5 Tiba Biotechnology Related Developments
- 11.1 Moderna Therapeutics
- 11.1.1 Moderna Therapeutics Corporation Information
- 11.1.2 Moderna Therapeutics Description and Business Overview
- 11.1.3 Moderna Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Moderna Therapeutics mRNA Vaccine Products Offered
- 11.1.5 Moderna Therapeutics Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 mRNA Vaccine Market Estimates and Projections by Region
- 12.1.1 Global mRNA Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global mRNA Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America mRNA Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: mRNA Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: mRNA Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: mRNA Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe mRNA Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: mRNA Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: mRNA Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: mRNA Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific mRNA Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: mRNA Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: mRNA Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: mRNA Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America mRNA Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: mRNA Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: mRNA Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: mRNA Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa mRNA Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: mRNA Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: mRNA Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: mRNA Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key mRNA Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 mRNA Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on mRNA Vaccine . Industry analysis & Market Report on mRNA Vaccine is a syndicated market report, published as Global mRNA Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of mRNA Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
